Art. 85b Directive (EU) 2001/83

In forcesince 21 Jul 2011cited 2×
1.

Persons brokering medicinal products shall ensure that the brokered medicinal products are covered by a marketing authorisation granted pursuant to Regulation (EC) No 726/2004 or by the competent authorities of a Member State in accordance with this Directive.

Persons brokering medicinal products shall have a permanent address and contact details in the Union, so as to ensure accurate identification, location, communication and supervision of their activities by competent authorities.

The requirements set out in points (d) to (i) of Article 80 shall apply mutatis mutandis to the brokering of medicinal products.

2.

Persons may only broker medicinal products if they are registered with the competent authority of the Member State of their permanent address referred to in paragraph 1. Those persons shall submit, at least, their name, corporate name and permanent address in order to register. They shall notify the competent authority of any changes thereof without unnecessary delay.

Persons brokering medicinal products who had commenced their activity before 2 January 2013 shall register with the competent authority by 2 March 2013.

The competent authority shall enter the information referred to in the first subparagraph in a register that shall be publicly accessible.

3.

The guidelines referred to in Article 84 shall include specific provisions for brokering.

4.

This Article shall be without prejudice to Article 111. Inspections referred to in Article 111 shall be carried out under the responsibility of the Member State where the person brokering medicinal products is registered.

If a person brokering medicinal products does not comply with the requirements set out in this Article, the competent authority may decide to remove that person from the register referred to in paragraph 2. The competent authority shall notify that person thereof.

  • Arzneimittelbetriebsordnung 20092Law

    … 4, Artikeln 84 und 85b Abs. 3 der Richtlinie 2001/83/EG zur Schaffung eines Gemeinschaftskodexes für Humanarzneimittel, ABl. L 311 vom 28.11.2001 S. 67, zuletzt geändert durch die Richtlinie 2011/62/EU zur Änderung der Richtlinie …

  • BVerwG, Urteil vom 25. Februar 2021 - 3 C 1/20Decision

    … Einbeziehung selbst der Arzneimittelvermittler in das System einer umfassenden mitgliedstaatlichen Kontrolle geht auf Art. 85b Abs. 1 Unterabs. 2 der Richtlinie 2001/83/EG in der durch die Richtlinie 2011/62/EU des Europäischen Parlaments …

    25 Feb 2021 · WBRE202100339